Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
REPORTS
April 21, 2022
This report debates the case for specific public investments in education in low- and lower-middle-income countries, drawing on evidence of what has worked not just in small-scale experiments but historically and in large-scale national programs. Its messages are intended more for economic policymak...
Blog Post
February 16, 2022
One of the most prestigious HTA agencies is the National Institute for Health and Care Excellence (NICE) in England, which has gained its reputation through highly vetted, transparent, and robust processes and recommendations. For LMICs that don’t have the capacity and/or the expertise to generate t...
Blog Post
January 20, 2022
In the wake of the COVID-19 crisis, many sub-Saharan African countries will face serious economic crises and shrinking public spending. If countries are unable to spend more, they need to spend better. Europe has leading expertise in building institutions for priority-setting in health, making it an...
WORKING PAPERS
December 16, 2021
How should governments and donors engage with the growing private sector in education in developing countries? Enrolment in private schools now exceeds 50 percent at the primary level in many major urban centres across Africa and Asia. Whilst the majority of these schools are small and independently...
Blog Post
December 13, 2021
In the language of economists, opportunity cost refers to the return or other forms of benefit that we could have received, but gave up, to take another course of action. In mathematical terms, it is the difference between the utility of what we have chosen and that from the foregone choice. Or, in ...
Blog Post
November 04, 2021
In this blog, we provide a rapid overview of the sources and wider uses of medicines data to strengthen health systems in LMIC settings, with a focus on Ghana. We argue that having credible and comprehensive data on medicines use leads to better decision making and better medicines policy. These are...